World-leading figures from healthcare and applied sciences have helped launch the HTC’s inaugural national meeting titled ‘Accelerating technology for patient benefit in colorectal disease’.
Over 150 delegates – including engineers, industry representatives, nanotechnology specialists, academics, NHS staff and patients – attended the meeting, which was held at the Royal Armouries in Leeds.
The one-day event included key-note presentations from high-profile and world-leading experts Sir Mark Welland, Head of the Nanoscience Centre at the University of Cambridge and Dr Richard Satava, Professor Emeritus of Surgery at the University of Washington Medical Centre (click on link below to view).
Sir Mark Welland said: “The challenge for applied sciences is to identify the real clinical need and end-user requirement before thinking about the solution. The HTC has an enormous opportunity to achieve this through the collaboration of scientists, engineers, companies, clinicians and patients – and translate these needs into viable and working solutions for the benefit of patients.”
Professor David Jayne, Clinical Director of the HTC and Professor of Surgery at of the University of Leeds, said: “This meeting provided the ideal platform to bring together a multidisciplinary group of experts to explore current technologies which might be applied to this field of unmet clinical need – ultimately for patient benefit. We were delighted with the number of collaborative ideas that emerged from the meeting and we’re now looking forward to ensuring the momentum continues from this event as the HTC develops.”
Click on the links below for the presentations from the meeting.